JAGE CATH LAB_Redacted.pdf

Control No: 20-RHCO-C-278

Version – February 2017

Period of Performance: ___1 OCT 2020________ to __30 SEPT 2023_____ or Total Value:

4. Authority:

X FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization.

5. Reasons for Authority Cited: There will be detrimental effects/serious injury to the mission of the requiring activity and to the Government which includes financial concerns if the document is not approved and the service cannot be provided by the Intended sole source Contractor.

6. Publicizing Contract Actions: For FAR Part 13 actions, the public display and synopsis requirements of FAR 5.101 and FAR 5.203 do not apply due to the $ threshold, X apply and will be followed, or do not apply due to an exception at

5.202 ______________________..

Requirement to post justification in accordance with FAR 8.405-6(b)(3), FAR 13.105(c), or FAR 16.505(a)(4)(iii)(A)

X Action is NOT a brand name restriction and is under $250K, no posting required

Action is a brand name restriction, under $25K, no posting required

Action is a brand name restriction, over $25K. It will be redacted and posted with the solicitation.

Action is a brand name restriction over $25K but will not be posted due to exception:

FAR 6.305(f)

FAR 8.405-6(b)(3)(iii)(A)

FAR 8.405-6(b)(3)(iii)(B)

FAR 8.405-6(b)(3)(iii)(C)

FAR 16.505(a)(4)(iii(C)

7. Market Research: Market research indicates the item falls within the commercial items definition as it is customarily used by the general public and has been so leased, or.

licensed to the general public. The contracting officer has provided consideration of socio-economical groups and will solicit this requirement as a sole source acquisition.

Based on the market research shows there is no adequate competition and will be procured limiting to one source, GE Medical Systems Information Technology.